Insider Transactions in Q3 2025 at Quest Diagnostics Inc (DGX)
Insider Transaction List (Q3 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 13
2025
|
Karthik Kuppusamy SVP, Clinical Solutions |
SELL
Payment of exercise price or tax liability
|
Direct |
123
-1.45%
|
$21,525
$175.91 P/Share
|
|
Aug 06
2025
|
Patrick Plewman SVP for Diagnostic Services |
SELL
Open market or private sale
|
Direct |
5,535
-11.85%
|
$968,625
$175.0 P/Share
|
|
Aug 06
2025
|
Patrick Plewman SVP for Diagnostic Services |
BUY
Exercise of conversion of derivative security
|
Direct |
3,560
+12.58%
|
$306,160
$86.63 P/Share
|
|
Jul 31
2025
|
Karthik Kuppusamy SVP, Clinical Solutions |
SELL
Open market or private sale
|
Direct |
2,210
-20.73%
|
$375,700
$170.0 P/Share
|
|
Jul 30
2025
|
Karthik Kuppusamy SVP, Clinical Solutions |
SELL
Open market or private sale
|
Direct |
8,269
-27.55%
|
$1,380,923
$167.4 P/Share
|
|
Jul 30
2025
|
Karthik Kuppusamy SVP, Clinical Solutions |
BUY
Exercise of conversion of derivative security
|
Direct |
8,269
+21.46%
|
$818,631
$99.4 P/Share
|
|
Jul 21
2025
|
Robert B Carter Director |
BUY
Small Acquisition
|
Direct |
7
+0.26%
|
$1,169
$167.5 P/Share
|
|
Jul 21
2025
|
Mark E Delaney SVP & Chief Commercial Officer |
BUY
Small Acquisition
|
Direct |
17
+0.23%
|
$2,839
$167.49 P/Share
|
|
Jul 21
2025
|
Vicky B Gregg Director |
BUY
Small Acquisition
|
Direct |
79
+0.43%
|
$13,193
$167.5 P/Share
|
|
Jul 21
2025
|
Wright Lassiter Iii Director |
BUY
Small Acquisition
|
Direct |
7
+0.08%
|
$1,169
$167.5 P/Share
|
|
Jul 21
2025
|
Karthik Kuppusamy SVP, Clinical Solutions |
BUY
Small Acquisition
|
Direct |
27
+0.25%
|
$4,509
$167.5 P/Share
|
|
Jul 21
2025
|
Patrick Plewman SVP for Diagnostic Services |
BUY
Small Acquisition
|
Direct |
80
+0.38%
|
$13,360
$167.49 P/Share
|
|
Jul 21
2025
|
Sam Samad Executive Vice President & CFO |
BUY
Small Acquisition
|
Direct |
72
+0.28%
|
$12,024
$167.5 P/Share
|
|
Jul 16
2025
|
Sam Samad Executive Vice President & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
850
-3.21%
|
$143,650
$169.01 P/Share
|